Home
URGN
URGN News

Latest UroGen Pharma Ltd. (URGN) News on July 27, 2024

Wall Street Analysts See a 149.01% Upside in Urogen Pharma (URGN): Can the Stock Really Move This High?

Zacks

9 days ago

Wall Street Analysts See a 149.01% Upside in Urogen Pharma (URGN): Can the Stock Really Move This High?

UroGen Pharma Stock Earns 91 RS Rating

Investor's Business Daily

a month ago

UroGen Pharma Stock Earns 91 RS Rating

UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

Business Wire

a month ago

UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

GlobeNewswire

a month ago

UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains?

Zacks

a month ago

Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains?

UroGen Catapults On 'Unprecedented' Results For Gel-Based Cancer Drug

Investor's Business Daily

a month ago

UroGen Catapults On 'Unprecedented' Results For Gel-Based Cancer Drug

MT Newswires

a month ago

Sector Update: Health Care Stocks Ease Late Afternoon

MT Newswires

a month ago

Sector Update: Health Care Stocks Softer Thursday Afternoon

MT Newswires

a month ago

Top Midday Gainers

MT Newswires

a month ago

UroGen Pharma Shares Surge After 'Unprecedented' Results on Bladder Cancer Therapy Trial

UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC

Business Wire

a month ago

UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

2 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

2 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

2 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

2 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

2 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

2 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

2 months ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024

Business Wire

2 months ago

UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024

UroGen Pharma to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

Business Wire

2 months ago

UroGen Pharma to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

UroGen Pharma Appoints David Lin as New Chief Commercial Officer

Business Wire

2 months ago

UroGen Pharma Appoints David Lin as New Chief Commercial Officer

UroGen Pharma to Present at the TD Cowen 5th Annual Oncology Innovation Summit

Business Wire

2 months ago

UroGen Pharma to Present at the TD Cowen 5th Annual Oncology Innovation Summit

UroGen Pharma First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

2 months ago

UroGen Pharma First Quarter 2024 Earnings: Misses Expectations

UroGen Pharma Ltd (URGN) Q1 2024 Earnings: Misses EPS Estimates, Revenue Slightly Above Expectations

GuruFocus.com

2 months ago

UroGen Pharma Ltd (URGN) Q1 2024 Earnings: Misses EPS Estimates, Revenue Slightly Above Expectations

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights

Business Wire

2 months ago

UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights

Shareholders in UroGen Pharma (NASDAQ:URGN) have lost 67%, as stock drops 11% this past week

Simply Wall St.

2 months ago

Shareholders in UroGen Pharma (NASDAQ:URGN) have lost 67%, as stock drops 11% this past week

UroGen Pharma to Participate at Upcoming Investor Conferences

Business Wire

3 months ago

UroGen Pharma to Participate at Upcoming Investor Conferences

New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO® Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy

Business Wire

3 months ago

New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO® Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy

UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024

Business Wire

3 months ago

UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024

New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial

Business Wire

3 months ago

New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial

UroGen Pharma to Report 2024 First Quarter Financial Results on Monday, May 13, 2024

Business Wire

3 months ago

UroGen Pharma to Report 2024 First Quarter Financial Results on Monday, May 13, 2024

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

Zacks

3 months ago

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers

Business Wire

3 months ago

UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers

UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Business Wire

3 months ago

UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

UroGen Pharma Ltd.'s (NASDAQ:URGN) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week

Simply Wall St.

3 months ago

UroGen Pharma Ltd.'s (NASDAQ:URGN) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

Business Wire

4 months ago

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

UroGen Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.

4 months ago

UroGen Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2023 Earnings Call Transcript

UroGen Pharma Ltd (URGN) Reports Solid JELMYTO Growth Amidst Financial Challenges

GuruFocus.com

4 months ago

UroGen Pharma Ltd (URGN) Reports Solid JELMYTO Growth Amidst Financial Challenges

Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates

Zacks

4 months ago

Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates

UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

Business Wire

4 months ago

UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024

Business Wire

5 months ago

UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024

UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference

Business Wire

5 months ago

UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference

Nurix Therapeutics, Inc. (NRIX) Surges 5.1%: Is This an Indication of Further Gains?

Zacks

5 months ago

Nurix Therapeutics, Inc. (NRIX) Surges 5.1%: Is This an Indication of Further Gains?

Ardmore Shipping Announces 2024 Investor Day in New York

PR Newswire

6 months ago

Ardmore Shipping Announces 2024 Investor Day in New York

NEWPARK RESOURCES ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 RESULTS CONFERENCE CALL AND WEBCAST DATE

PR Newswire

6 months ago

NEWPARK RESOURCES ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 RESULTS CONFERENCE CALL AND WEBCAST DATE

UroGen Pharma to Participate at Upcoming Investor Conferences

Business Wire

6 months ago

UroGen Pharma to Participate at Upcoming Investor Conferences

AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Conference

Business Wire

6 months ago

AN2 Therapeutics to Present at Oppenheimer Healthcare Life Sciences Conference

Redwood Trust Announces Dividend Tax Information for 2023

Business Wire

6 months ago

Redwood Trust Announces Dividend Tax Information for 2023

GuruFocus.com

6 months ago

Heritage Commerce Corp Reports $64.4 Million Full Year Net Income for 2023

Heritage Commerce (HTBK) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

6 months ago

Heritage Commerce (HTBK) Reports Q4 Earnings: What Key Metrics Have to Say

PROG Holdings Announces Cost Savings Actions

Business Wire

6 months ago

PROG Holdings Announces Cost Savings Actions

Hanmi Financial Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

6 months ago

Hanmi Financial Full Year 2023 Earnings: EPS Beats Expectations

QCR Holdings Inc (QCRH) Announces Record Earnings for Q4 and Full Year 2023

GuruFocus.com

6 months ago

QCR Holdings Inc (QCRH) Announces Record Earnings for Q4 and Full Year 2023

Magic Software Enterprises Ltd.'s (NASDAQ:MGIC) Stock Has Fared Decently: Is the Market Following Strong Financials?

Simply Wall St.

6 months ago

Magic Software Enterprises Ltd.'s (NASDAQ:MGIC) Stock Has Fared Decently: Is the Market Following Strong Financials?

UroGen Initiates Submission of a Rolling NDA to the FDA for UGN-102

Business Wire

6 months ago

UroGen Initiates Submission of a Rolling NDA to the FDA for UGN-102

Associated Press Finance

6 months ago

First Community Bancshares: Q4 Earnings Snapshot

Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call

PR Newswire

6 months ago

Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call

First Community Bankshares, Inc. Announces Fourth Quarter 2023 Results and Quarterly Cash Dividend

GlobeNewswire

6 months ago

First Community Bankshares, Inc. Announces Fourth Quarter 2023 Results and Quarterly Cash Dividend

Q1’s Rising Stars: 3 Flying Car Stocks for Your Must-Watch List

InvestorPlace

6 months ago

Q1’s Rising Stars: 3 Flying Car Stocks for Your Must-Watch List

Baijiayun Announces Changes in Management and Board of Directors

PR Newswire

6 months ago

Baijiayun Announces Changes in Management and Board of Directors

Dividend Challengers List Ranked By Yield: Top 30

Insider Monkey

6 months ago

Dividend Challengers List Ranked By Yield: Top 30

UroGen Secures Exclusive License from medac GmbH to Develop a Next-Generation Novel Mitomycin-Based Formulation for Urothelial Cancers

Business Wire

6 months ago

UroGen Secures Exclusive License from medac GmbH to Develop a Next-Generation Novel Mitomycin-Based Formulation for Urothelial Cancers

Lindsay to Invest Over $50M to Expand, Modernize Manufacturing Facility

PR Newswire

6 months ago

Lindsay to Invest Over $50M to Expand, Modernize Manufacturing Facility

When Will MoneyLion Inc. (NYSE:ML) Turn A Profit?

Simply Wall St.

6 months ago

When Will MoneyLion Inc. (NYSE:ML) Turn A Profit?

Q4 Earnings Highs And Lows: Conagra (NYSE:CAG) Vs The Rest Of The Packaged Food Stocks

StockStory

6 months ago

Q4 Earnings Highs And Lows: Conagra (NYSE:CAG) Vs The Rest Of The Packaged Food Stocks

Reflecting On Household Products Stocks’ Q3 Earnings: Reynolds (NASDAQ:REYN)

StockStory

6 months ago

Reflecting On Household Products Stocks’ Q3 Earnings: Reynolds (NASDAQ:REYN)

UroGen Pharma to Participate in the B. Riley Healthcare Conference

Business Wire

6 months ago

UroGen Pharma to Participate in the B. Riley Healthcare Conference

LendingClub Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

PR Newswire

7 months ago

LendingClub Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Register for Capital Link’s 2024 Virtual Corporate Presentation Series

GlobeNewswire

7 months ago

Register for Capital Link’s 2024 Virtual Corporate Presentation Series

Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate

GlobeNewswire

7 months ago

Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate

After $700M Deal, UCLA To Transform Westside Pavilion Into Research Park

Commercial Observer

7 months ago

After $700M Deal, UCLA To Transform Westside Pavilion Into Research Park

Biotech CEOs Are Buying Up Their Surging Stocks

Barrons.com

7 months ago

Biotech CEOs Are Buying Up Their Surging Stocks

Dividend Contenders List Ranked By Yield: Top 25

Insider Monkey

7 months ago

Dividend Contenders List Ranked By Yield: Top 25

TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock

Business Wire

7 months ago

TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock

Business Wire

7 months ago

CION Investment Corporation Announces Special Year-End 2023 Distribution of $0.15 Per Share

Preferred Bank Announces Increased Cash Dividend

GlobeNewswire

7 months ago

Preferred Bank Announces Increased Cash Dividend

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thomson Reuters StreetEvents

8 months ago

Q2 2024 Smith & Wesson Brands Inc Earnings Call

TTEC wins Talent Acquisition Team of the Year at OnCon Icon Awards

PR Newswire

8 months ago

TTEC wins Talent Acquisition Team of the Year at OnCon Icon Awards

Investors in Playa Hotels & Resorts (NASDAQ:PLYA) have seen decent returns of 44% over the past three years

Simply Wall St.

8 months ago

Investors in Playa Hotels & Resorts (NASDAQ:PLYA) have seen decent returns of 44% over the past three years

Insider Sell: Director James Courter Sells 12,725 Shares of Genie Energy Ltd (GNE)

GuruFocus.com

8 months ago

Insider Sell: Director James Courter Sells 12,725 Shares of Genie Energy Ltd (GNE)

Cool Company Ltd.: 2023 AGM Results Notification

Business Wire

8 months ago

Cool Company Ltd.: 2023 AGM Results Notification

Shareholders in UroGen Pharma (NASDAQ:URGN) are in the red if they invested five years ago

Simply Wall St.

8 months ago

Shareholders in UroGen Pharma (NASDAQ:URGN) are in the red if they invested five years ago

Vital Energy Announces Conversion of 2.0% Cumulative Mandatorily Convertible Series A Preferred Stock

GlobeNewswire

8 months ago

Vital Energy Announces Conversion of 2.0% Cumulative Mandatorily Convertible Series A Preferred Stock

UWM’s Jason Bressler on the role of failure in tech innovation

HousingWire

8 months ago

UWM’s Jason Bressler on the role of failure in tech innovation

Paragon 28 (FNA) New Staple System Expands Ankle Device Line

Zacks

8 months ago

Paragon 28 (FNA) New Staple System Expands Ankle Device Line

UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2023 Earnings Call Transcript

UroGen Pharma Ltd (URGN) Reports Growth in Q3 Revenue and Progress in Clinical Trials

GuruFocus.com

8 months ago

UroGen Pharma Ltd (URGN) Reports Growth in Q3 Revenue and Progress in Clinical Trials

Share on Social Networks: